Literature DB >> 3567020

Excretion of chloroquine, dapsone and pyrimethamine in human milk.

M D Edstein, J R Veenendaal, K Newman, R Hyslop.   

Abstract

The concentration of chloroquine (CQ), dapsone (DDS) and pyrimethamine (PYR) in plasma and milk were measured following the coadministration of a single dose of chloroquine and Maloprim to lactating women. The milk to plasma area under the concentration-time curve (AUC) ratio ranged from 1.96 to 4.26 for CQ, 0.22 to 0.45 for DDS and 0.46 to 0.66 for PYR. Assuming a daily milk ingestion of 1 l by the infant, the maximum percentage of the maternal dose for CQ, DDS and PYR in milk was 4.2%, 14.3% and 45.6%, respectively, over a 9 day period.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3567020      PMCID: PMC1401222          DOI: 10.1111/j.1365-2125.1986.tb02967.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.

Authors:  J C Cavallito; C A Nichol; W D Brenckman; R L Deangelis; D R Stickney; W S Simmons; C W Sigel
Journal:  Drug Metab Dispos       Date:  1978 May-Jun       Impact factor: 3.922

2.  Excretion of hydroxychloroquine in human milk.

Authors:  R L Nation; L P Hackett; L J Dusci; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

3.  Quantification of antimalarial drugs. II. Simultaneous measurement of dapsone, monoacetyldapsone and pyrimethamine in human plasma.

Authors:  M Edstein
Journal:  J Chromatogr       Date:  1984-05-11

4.  Hemolytic anemia induced by dapsone transmitted through breast milk.

Authors:  S W Sanders; J J Zone; R L Foltz; K G Tolman; D E Rollins
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

Review 5.  Malaria and alterations in immune reactivity.

Authors:  W P Weidanz
Journal:  Br Med Bull       Date:  1982-05       Impact factor: 4.291

6.  Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.

Authors:  G Alván; L Ekman; B Lindström
Journal:  J Chromatogr       Date:  1982-04-16

7.  [Chloroquine transfer to milk. A case].

Authors:  E Deturmeny; A Viala; A Durand; Y Nosny
Journal:  Therapie       Date:  1984 Jul-Aug       Impact factor: 2.070

Review 8.  Malaria 1984. Part I. Malaria prophylaxis.

Authors:  F H Spracklen
Journal:  S Afr Med J       Date:  1984-06-30

9.  Breast-milk production in Australian women.

Authors:  S Rattigan; A V Ghisalberti; P E Hartmann
Journal:  Br J Nutr       Date:  1981-03       Impact factor: 3.718

10.  Dapsone in saliva and plasma of man.

Authors:  J H Peters; J F Murray; G R Gordon; R H Gelber
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

View more
  10 in total

Review 1.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

2.  Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.

Authors:  Sam Salman; Francisca Baiwog; Madhu Page-Sharp; Susan Griffin; Harin A Karunajeewa; Ivo Mueller; Stephen J Rogerson; Peter M Siba; Kenneth F Ilett; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.

Authors:  Brioni R Moore; Sam Salman; John Benjamin; Madhu Page-Sharp; Gumal Yadi; Kevin T Batty; Peter M Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

4.  Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers.

Authors:  Irwin Law; Kenneth F Ilett; L Peter Hackett; Madhu Page-Sharp; Francesca Baiwog; Servina Gomorrai; Ivo Mueller; Harin A Karunajeewa; Timothy M E Davis
Journal:  Br J Clin Pharmacol       Date:  2008-02-15       Impact factor: 4.335

Review 5.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 6.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 7.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 8.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 9.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

Review 10.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.